PHENYLEPHRINE/COOPER EY.DRO.SOL 5% Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

phenylephrine/cooper ey.dro.sol 5%

ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - phenylephrine hydrochloride - ey.dro.sol (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ) - 5% - phenylephrine hydrochloride 50mg - phenylephrine

PHENYLEPHRINE/COOPER EY.DRO.SOL 10 % Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

phenylephrine/cooper ey.dro.sol 10 %

ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - phenylephrine hydrochloride - ey.dro.sol (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ) - 10 % - phenylephrine hydrochloride 100mg - phenylephrine

PHENYLEPHRINE HYDROCHLORIDE solution/ drops USA - engelsk - NLM (National Library of Medicine)

phenylephrine hydrochloride solution/ drops

akorn - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride 25 mg in 1 ml - phenylephrine hydrochloride ophthalmic solution, usp 2.5% and 10%, is indicated to dilate the pupil. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age due to the increased risk of systemic toxicity. phenylephrine hydrochloride ophthalmic solution 2.5% should be used in these patients [see dosage and administration (2.2)] . animal reproduction studies have not been conducted with topical phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human breast milk. because many drugs are excreted in human milk, caution should be exercised when phenylephrine hydrochloride ophthalmic solution 2.5% and 10% is administered to a nursing woman. phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in pediatric patients less than 1 year of age [see contraindications (4.2) ]. no overall differences in safety and effectiveness have been observed between elderly and younger adult patients.

Phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe Malta - engelsk - Medicines Authority

phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe

laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - phenylephrine hydrochloride - solution for injection in a pre-filled syringe - phenylephrine hydrochloride 50 µg/ml - cardiac therapy

Phenylephrine 100 micrograms/ml solution for injection/infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

phenylephrine 100 micrograms/ml solution for injection/infusion

laboratoire aguettant - phenylephrine hydrochloride - solution for injection/infusion - 100 microgram(s)/millilitre - phenylephrine

Phenylephrine Hydrochloride 10 mg/ml solution for injection/infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

phenylephrine hydrochloride 10 mg/ml solution for injection/infusion

athlone laboratories ltd - phenylephrine hydrochloride - solution for injection/infusion - phenylephrine

Phenylephrine Hydrochloride 10 mg/ml solution for injection/infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

phenylephrine hydrochloride 10 mg/ml solution for injection/infusion

athlone pharmaceuticals limited - phenylephrine hydrochloride - solution for injection/infusion - phenylephrine

PHENYLEPHRINE MEDAC 0,05 mg/mL, solution injectable Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

phenylephrine medac 0,05 mg/ml, solution injectable

unimedic pharma ab - phényléphrine 0 - solution - 0,05 mg - pour 1 ml > phényléphrine 0,05 mg sous forme de : chlorhydrate de phényléphrine - stimulant cardiaque a l'exclusion des glycosides cardiaques - classe pharmacothérapeutique : stimulant cardiaque a l'exclusion des glycosides cardiaques, code atc : c01ca06.phenylephrine medac est utilisé pour traiter une baisse de la pression artérielle qui peut se produire lors de différents types d'anesthésie.

PHENYLEPHRINE MEDAC 0,1 mg/mL, solution injectable Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

phenylephrine medac 0,1 mg/ml, solution injectable

unimedic pharma ab - phényléphrine 0 - solution - 0,1 mg - pour 1 ml > phényléphrine 0,1 mg sous forme de : chlorhydrate de phényléphrine - stimulant cardiaque a l'exclusion des glycosides cardiaques - classe pharmacothérapeutique : stimulant cardiaque a l'exclusion des glycosides cardiaques, code atc : c01ca06.phenylephrine medac est utilisé pour traiter une baisse de la pression artérielle qui peut se produire lors de différents types d'anesthésie.

PHENYLEPHRINE 10MG/ML SOLUTION FOR INJECTION OR INFUSION Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

phenylephrine 10mg/ml solution for injection or infusion

beacon pharmaceuticals limited (0000010730) the bower 4 roundwood avenue, stockley park, heathrow, ub11 1af - phenylephrine hydrochloride - solution for injection or infusion - 10mg/ml - phenylephrine hydrochloride (0000061767) 10mg - phenylephrine